Medical Letter on the CDC and FDA

West Nile Virus Immunology - New west nile virus immunology study findings have been published by scientists at University of Pittsburgh, Department of Pathology

Aida Pharmaceuticals, Inc. - Aida Files 10Q

Allergies - FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription

Allergies - The American Pharmacists Association Supports Consumer Education About OTC Medications

Amedica Corporation - Amedica Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System

Artes Medical, Inc. - Artes Medical to Present at Lazard Capital Markets Healthcare Conference

Arthritis - Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis

Behavior - MIT: 'Micro' livers could aid drug screening

Biotechnology Business - Biovail Confirms FDA Class 2 Status for BVF-033 Submission

Bipolar Disorder - Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA

Breast Cancer - Aurora Dedicated Breast MRI Now Available at the Toledo Hospital Radiology and Diagnostic Imaging Center

Breast Cancer - Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer

Cancer - ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study

Cholera - USAID Sends Emergency Assistance to Djibouti for Cholera

Clinical Trial Research - Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans

Colon Cancer - FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer

Cystic Fibrosis - Gilead Submits New Drug Application to U.S. FDA for Aztreonam Lysine for Inhalation for Cystic Fibrosis

Diphtheria - Akorn, Inc. Announces FDA Approval for Unit Dose Preservative Free Tetanus Diphtheria Vaccine

Drug Development - Brian J.G. Pereira, M.D. Joins Biodel's Board of Directors

Drug Development - FDA Accepts Ranexa(R) sNDA and NDA for Filing

Drugs - BioSante Pharmaceuticals Announces License Agreement for its CaP Technology in Aesthetic Medicine

Endometrial Ablation - Three New In-Office Studies on Essure(R) Procedure Presented at AAGL Meeting, Including First Study on Third-Generation System

GlaxoSmithKline - GSK to Acquire Reliant Pharmaceuticals

Heart Disease - CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes

Hepatitis - GNI Announces IND Approval in China for Novel Liver Disease Drug F351

Hitachi Medical Systems America - Hitachi Commercializes OASIS, the Highest Field Strength Open MRI

HIV/AIDS - CHF International Named Global Fund Principal Recipient in Honduras

Huntington Disease - Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program

Hypertension - Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients L

ISPE (International Society for Pharmaceutical - ISPE Awards Russ Somma, Ph.D. Max Seales Yonker Member of the Year

Labopharm Inc. - Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol

Lifeline Biotechnologies, Inc. - Lifeline Biotechnologies, Inc. in Discussions with Firms to Begin Filing FDA 510(k) Submission for First Warning System(TM)

Lifeline Biotechnologies, Inc. - Lifeline Biotechnologies, Inc. Receives Update on Development Status of First Warning System(TM)

Liver Cancer - Nexavar First FDA-Approved Drug Therapy for Liver Cancer

Medicare and Medicaid - Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities

Monoclonal Antibodies - CHMP Adopts Negative Opinion on Appeal on European Application for natalizumab for the Treatment of Crohn's Disease

Novo Nordisk Inc. - Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)

Obstructive Sleep Apnea - CHAD Therapeutics to Sell Its Oxygen Conserver Business and Focus on Development and Marketing of Patented Medical Devices for the Sleep Disorder Market

Oncology - MEDIAN Technologies Lesion Management Solutions Set the Trend in Diagnostic Oncology Imaging at RSNA 2007

Patents - IMPAX Comments on Lawsuit Related to Generic Version of Opana(R) ER

Prostate Cancer - CareToLive Reports: the FDA Fiddles While 30,000 Men Burn

Psoriasis - Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

Regulatory Actions - AFP Imaging Corporation Receives Canadian Government License to Market Newtom(TM) VG 3D Cone Beam Computed Tomography Scanner

Schizophrenia - SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia

Vaccine Safety - 92 Medicines and Vaccines now in Development for HIV/AIDS

Vaccine Safety - Poxvirus' ability to hide from the immune system may aid vaccine design